United Against Rabies Forum: The first 2 years.
| Autor: | Tidman R; World Organisation for Animal Health, Paris, France., Fahrion AS; Institute of International Animal Health/One Health, Friedrich-Loeffler-Institute, Greifswald-Riems, Germany., Thumbi SM; Center for Epidemiological Modelling and Analysis, University of Nairobi, Nairobi, Kenya.; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.; Paul G. Allen School for Global Health, Washington State University, Pullman, WA, United States., Wallace RM; Centers for Disease Control and Prevention, Atlanta, GA, United States., De Balogh K; Food and Agriculture Organization of the United Nations, Rome, Italy., Iwar V; Economic Community of West African States Commission, Abuja, Nigeria., Yale G; Mission Rabies, Panjim, India., Dieuzy-Labaye I; World Organisation for Animal Health, Paris, France. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Frontiers in public health [Front Public Health] 2023 Mar 23; Vol. 11, pp. 1010071. Date of Electronic Publication: 2023 Mar 23 (Print Publication: 2023). |
| DOI: | 10.3389/fpubh.2023.1010071 |
| Abstrakt: | Rabies continues to kill an estimated 59,000 people annually, with up to 99% of human cases transmitted by domestic dogs. The elimination of human deaths from dog-mediated rabies is achievable by applying a One Health approach, and the framework to do this is outlined in Zero by 30: the Global Strategic Plan to end human deaths from dog-mediated rabies by 2030. To build on this global goal, and implement the approaches set out in Zero by 30, the United Against Rabies Forum was launched in 2020. This paper gives a review of the objectives, governance, activities and achievements of the United Against Rabies Forum to date. It also outlines ongoing work, and next steps as the United Against Rabies Forum reviews its first 2 years of activities and identifies priority areas for the coming 12 months. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2023 Tidman, Fahrion, Thumbi, Wallace, De Balogh, Iwar, Yale and Dieuzy-Labaye.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|